论文部分内容阅读
目的探究冠心病采用阿托伐他汀与曲美他嗪联合治疗的临床疗效,旨在为冠心病的治疗寻找更佳的治疗方案。方法选取本院在2014年1月至2016年1月两年内收治的冠心病患者151例,将其分为A组(n=75)和B组(n=76),B组仅选用曲美他嗪一种药物治疗,A组则B组的基础上联合阿托伐他汀共同治疗,对比两组患者的临床治疗效果、血脂变化以及心绞痛发作频率和持续时间的变化情况。结果 A组(93.33%)临床有效率显著高于B组(81.58%);A组患者血脂各项指标恢复情况明显优于B组;经治疗后,B组患者心绞痛发作比A组患者频繁,且平均持续时间要长,以上差异均有统计学意义(P<0.05)。结论冠心病采用阿托伐他汀与曲美他嗪联合治疗可以有效提高临床有效率,减少患者心绞痛发作频率和持续时间,有利于减轻患者痛苦和提高其预后,此方法在临床上具有一定的参考和应用价值。
Objective To investigate the clinical efficacy of combination therapy with atorvastatin and trimetazidine in coronary heart disease and to find a better treatment for coronary heart disease. Methods 151 patients with CHD who were admitted to our hospital from January 2014 to January 2016 were selected and divided into group A (n = 75) and group B (n = 76), while group B A group was treated with atrazine, while group A was treated with atorvastatin combined with group B, and the clinical effects, changes of blood lipids and the frequency and duration of angina pectoris were compared between the two groups. Results The clinical efficiency of group A (93.33%) was significantly higher than that of group B (81.58%). The recovery of blood lipid in group A was significantly better than that of group B. After treatment, angina pectoris in group B was more frequent than group A, And the average duration was longer, the above differences were statistically significant (P <0.05). Conclusion The combination of atorvastatin and trimetazidine in coronary heart disease can effectively improve the clinical efficiency, reduce the frequency and duration of angina pectoris, reduce the pain and improve the prognosis of patients. This method has some reference in clinical practice And application value.